These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders. Yasui-Furukori N, Kaneko S. Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048 [Abstract] [Full Text] [Related]
5. Hypothyroidism induced by quetiapine: a case report. Liappas J, Paparrigopoulos T, Mourikis I, Soldatos C. J Clin Psychopharmacol; 2006 Apr; 26(2):208-9. PubMed ID: 16633154 [No Abstract] [Full Text] [Related]
6. Effect of paroxetine on thyroid hormone levels in severely depressed patients. König F, Hauger B, von Hippel C, Wolfersdorf M, Kaschka WP. Neuropsychobiology; 2000 Apr; 42(3):135-8. PubMed ID: 11015031 [Abstract] [Full Text] [Related]
11. Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events. Ramasubbu R. Can J Psychiatry; 2003 May; 48(4):281-2. PubMed ID: 12776398 [No Abstract] [Full Text] [Related]
17. Toxic epidermal necrolysis after paroxetine treatment. Ahmed R, Eagleton C. N Z Med J; 2008 May 23; 121(1274):86-9. PubMed ID: 18535650 [Abstract] [Full Text] [Related]
20. Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature. Azaz-Livshits T, Hershko A, Ben-Chetrit E. Pharmacopsychiatry; 2002 May 23; 35(3):112-5. PubMed ID: 12107856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]